vs
Korro Bio, Inc.（KRRO）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
Korro Bio, Inc.的季度营收约是Arcadia Biosciences, Inc.的1.4倍（$1.3M vs $901.0K），Arcadia Biosciences, Inc.同比增速更快（-25.8% vs -43.1%）
Korro Bio是一家处于临床阶段的生物技术企业，专注于开发针对罕见及严重遗传疾病的新型RNA编辑疗法，依托专有寡核苷酸平台靶向致病基因突变，核心管线覆盖眼科、呼吸系统与神经肌肉疾病领域，致力于满足全球未被满足的医疗需求。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
KRRO vs RKDA — 直观对比
营收规模更大
KRRO
是对方的1.4倍
$901.0K
营收增速更快
RKDA
高出17.3%
-43.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3M | $901.0K |
| 净利润 | — | $-1.3M |
| 毛利率 | — | 21.4% |
| 营业利润率 | — | -152.8% |
| 净利率 | — | -148.3% |
| 营收同比 | -43.1% | -25.8% |
| 净利润同比 | -136.1% | 67.1% |
| 每股收益（稀释后） | — | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRRORKDA
| Q4 25 | $1.3M | $901.0K | ||
| Q3 25 | $1.1M | $1.3M | ||
| Q2 25 | $1.5M | $1.5M | ||
| Q1 25 | $2.5M | $1.2M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $0 | $1.5M | ||
| Q2 24 | $0 | $1.3M | ||
| Q1 24 | $0 | $987.0K |
净利润KRRORKDA
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-18.1M | $856.0K | ||
| Q2 25 | $-25.8M | $-4.5M | ||
| Q1 25 | $-23.4M | $2.6M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $-21.0M | $-1.6M | ||
| Q2 24 | $-21.8M | $1.1M | ||
| Q1 24 | $-19.6M | $-2.4M |
毛利率KRRORKDA
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | — | 32.9% | ||
| Q2 24 | — | 51.5% | ||
| Q1 24 | — | 52.3% |
营业利润率KRRORKDA
| Q4 25 | — | -152.8% | ||
| Q3 25 | -1764.9% | -88.5% | ||
| Q2 25 | -1863.2% | -34.4% | ||
| Q1 25 | -981.2% | 44.2% | ||
| Q4 24 | — | -187.7% | ||
| Q3 24 | — | -114.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -160.9% |
净利率KRRORKDA
| Q4 25 | — | -148.3% | ||
| Q3 25 | -1657.0% | 65.7% | ||
| Q2 25 | -1765.1% | -306.4% | ||
| Q1 25 | -917.1% | 216.6% | ||
| Q4 24 | — | -334.5% | ||
| Q3 24 | — | -104.9% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | -245.5% |
每股收益（稀释后）KRRORKDA
| Q4 25 | — | $-0.97 | ||
| Q3 25 | $-1.92 | $0.62 | ||
| Q2 25 | $-2.74 | $-3.26 | ||
| Q1 25 | $-2.49 | $1.90 | ||
| Q4 24 | — | $-2.99 | ||
| Q3 24 | $-2.26 | $-1.18 | ||
| Q2 24 | $-2.43 | $0.78 | ||
| Q1 24 | $-2.44 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $75.2M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $51.4M | $4.1M |
| 总资产 | $113.5M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KRRORKDA
| Q4 25 | $75.2M | $4.6M | ||
| Q3 25 | $92.5M | $5.9M | ||
| Q2 25 | $96.4M | $4.4M | ||
| Q1 25 | $115.0M | $3.2M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | $137.0M | $6.6M | ||
| Q2 24 | $157.4M | $8.1M | ||
| Q1 24 | $138.8M | $8.5M |
股东权益KRRORKDA
| Q4 25 | $51.4M | $4.1M | ||
| Q3 25 | $99.0M | $5.4M | ||
| Q2 25 | $115.1M | $4.5M | ||
| Q1 25 | $139.0M | $8.9M | ||
| Q4 24 | — | $6.2M | ||
| Q3 24 | $179.6M | $10.3M | ||
| Q2 24 | $198.1M | $11.7M | ||
| Q1 24 | $151.4M | $10.6M |
总资产KRRORKDA
| Q4 25 | $113.5M | $6.5M | ||
| Q3 25 | $161.6M | $8.6M | ||
| Q2 25 | $180.4M | $7.8M | ||
| Q1 25 | $202.2M | $13.0M | ||
| Q4 24 | — | $13.5M | ||
| Q3 24 | $243.5M | $15.2M | ||
| Q2 24 | $249.6M | $17.4M | ||
| Q1 24 | $198.0M | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-78.6M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-79.1M | — |
| 自由现金流率自由现金流/营收 | -6120.7% | — |
| 资本支出强度资本支出/营收 | 40.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-140.4M | — |
8季度趋势，按日历期对齐
经营现金流KRRORKDA
| Q4 25 | $-78.6M | $-861.0K | ||
| Q3 25 | $-17.2M | $-257.0K | ||
| Q2 25 | $-19.2M | $-2.0M | ||
| Q1 25 | $-24.5M | $-1.6M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $-16.1M | $-1.8M | ||
| Q2 24 | $-14.6M | $-2.5M | ||
| Q1 24 | $-21.9M | $-3.2M |
自由现金流KRRORKDA
| Q4 25 | $-79.1M | — | ||
| Q3 25 | $-17.4M | — | ||
| Q2 25 | $-19.4M | — | ||
| Q1 25 | $-24.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-21.0M | — | ||
| Q2 24 | $-20.6M | $-2.5M | ||
| Q1 24 | $-27.5M | $-3.2M |
自由现金流率KRRORKDA
| Q4 25 | -6120.7% | — | ||
| Q3 25 | -1592.1% | — | ||
| Q2 25 | -1326.6% | — | ||
| Q1 25 | -963.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -188.3% | ||
| Q1 24 | — | -326.5% |
资本支出强度KRRORKDA
| Q4 25 | 40.1% | 0.0% | ||
| Q3 25 | 16.1% | 0.0% | ||
| Q2 25 | 9.6% | 0.0% | ||
| Q1 25 | 4.7% | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 1.3% |
现金转化率KRRORKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
